Corporate bond medicine is working
The corporate bond market looked like one of the worst casualties of 2008’s turmoil. Its vital signs were weak, its pulse was fading and only a prescription of generous spreads and a course of utilities transactions helped the sector recover in the final weeks of the year. But it’s not time for the patient to jump out of bed and start flirting with the nurses — the all-clear is a long way off yet.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts